Skip to main content
OpenTrials

Clinical trial condition

Gastro-enteropancreatic neuroendocrine tumor

Explore clinical trials studying Gastro-enteropancreatic neuroendocrine tumor. Study availability and eligibility vary by location and protocol.

46 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Gastro-enteropancreatic neuroendocrine tumor trial results

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

NCT03220217

Conditions
Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Medical University of Innsbruck Innsbruck, Austria
  • University Clinic for Radiology and Nuclear Medicine Vienna, Austria
  • Aarhus University Hospital Aarhus, Denmark
View Trial Details
Completed

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

NCT03017690

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Ochsner Medical Center Kenner Kenner, Louisiana, United States
  • Mercy Medical Center Baltimore, Maryland, United States
  • National Translational Research Group East Setauket, New York, United States
View Trial Details

Related conditions